• 1. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 2. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 3. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 4. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 5. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002

Introduction to 2-Bromo-N-butyl-4-nitroaniline (CAS No. 1157464-19-1)

2-Bromo-N-butyl-4-nitroaniline, identified by the Chemical Abstracts Service Number (CAS No.) 1157464-19-1, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the class of nitroaromatic amines, characterized by its brominated and butyl-substituted aniline backbone. The structural features of 2-Bromo-N-butyl-4-nitroaniline make it a versatile intermediate in the synthesis of various bioactive molecules, particularly in the development of novel therapeutic agents.

The nitro group at the para position relative to the bromine atom introduces a region of high reactivity, enabling further functionalization through reduction or condensation reactions. This property is particularly valuable in drug discovery, where modifications at specific positions can enhance binding affinity or metabolic stability. The bromo substituent, on the other hand, provides a handle for cross-coupling reactions such as Suzuki or Buchwald-Hartwig couplings, which are widely employed in constructing complex molecular architectures.

In recent years, 2-Bromo-N-butyl-4-nitroaniline has been explored as a key precursor in the synthesis of small-molecule inhibitors targeting various biological pathways. For instance, studies have demonstrated its utility in generating derivatives with potential antimicrobial and anticancer properties. The butyl chain appended to the aniline core contributes to hydrophobic interactions, which can be leveraged to improve membrane permeability and oral bioavailability of drug candidates.

One notable application of 2-Bromo-N-butyl-4-nitroaniline is in the development of kinase inhibitors. Kinases are enzymes that play crucial roles in cell signaling and are frequently dysregulated in diseases such as cancer. By incorporating this compound into library screens, researchers have identified novel scaffolds that exhibit inhibitory activity against specific kinases. The bromine atom allows for further derivatization via transition-metal-catalyzed reactions, enabling the optimization of potency and selectivity.

The pharmaceutical industry has also shown interest in 2-Bromo-N-butyl-4-nitroaniline for its potential use in central nervous system (CNS) drug development. The structural motif is reminiscent of known pharmacophores that interact with neurotransmitter receptors. Preliminary studies suggest that derivatives of this compound may modulate receptor activity, offering a new avenue for treating neurological disorders such as Alzheimer's disease and Parkinson's disease.

From a synthetic chemistry perspective, 2-Bromo-N-butyl-4-nitroaniline serves as a valuable building block due to its compatibility with multiple reaction protocols. It can be easily modified through nucleophilic aromatic substitution, metal-catalyzed coupling reactions, or catalytic hydrogenation. These transformations allow chemists to tailor the compound's properties for specific applications, whether it be enhancing solubility, improving metabolic stability, or introducing additional functional groups.

The demand for high-quality intermediates like 2-Bromo-N-butyl-4-nitroaniline has been bolstered by advancements in high-throughput screening technologies. These platforms rely on large libraries of diverse compounds to identify hits with desired biological activity rapidly. By incorporating such intermediates into synthetic pipelines, pharmaceutical companies can accelerate their drug discovery programs significantly.

In conclusion, 2-Bromo-N-butyl-4-nitroaniline (CAS No. 1157464-19-1) represents a promising candidate for further exploration in medicinal chemistry and chemical biology. Its unique structural features offer multiple avenues for functionalization, making it an indispensable tool for researchers seeking to develop innovative therapeutic solutions. As our understanding of biological pathways continues to expand, compounds like this are likely to play an increasingly critical role in addressing unmet medical needs.

• 6911-88-2(2-Bromo-N-methyl-4-nitroaniline)
• 1150271-15-0(N-Benzyl-2-bromo-4-nitroaniline)
• 64230-23-5(N,N-Dimethyl 2-bromo-4-nitroaniline)
• 108485-08-1(N-Ethyl 2-Bromo-4-nitroaniline)
• 1150271-18-3(N,N-Diethyl 2-Bromo-4-nitroaniline)
• 1250973-55-7(2-Bromo-N-cyclopropyl-4-nitroaniline)
• 1157464-28-2(2-Bromo-4-nitro-N-propylaniline)
• 57045-86-0(N-Acetyl 2-bromo-4-nitroaniline)
• 1072944-61-6(1-(2-Bromo-4-nitrophenyl)piperidin-4-ol)
• 952664-76-5(2-Bromo-N-(tert-butyl)-4-nitroaniline)